From: Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma
 | Variables | SMARCC1 expression | Total | χ2 | P value | |
---|---|---|---|---|---|---|
low | high | |||||
Age (year) | < 50 | 14 | 25 | 39 | 0.163 | 0.687 |
≥ 50 | 22 | 33 | 55 |  |  | |
Sex | Female | 3 | 11 | 14 | 1.981 | 0.159 |
Male | 33 | 47 | 80 | Â | Â | |
Grade | I–II | 29 | 31 | 60 | 8.247 | 0.004 |
III | 6 | 27 | 33 | Â | Â | |
T stage | I–II | 27 | 33 | 60 | 3.153 | 0.076 |
III–IV | 9 | 25 | 34 |  |  | |
TNM stage | I–II | 27 | 33 | 60 | 3.153 | 0.076 |
III–IV | 9 | 25 | 34 |  |  | |
Cirrhosis | Negative | 7 | 12 | 19 | 0.001 | 0.981 |
Positive | 26 | 44 | 70 | Â | Â | |
Hepetitis | Negative | 1 | 4 | 5 | 0.154 | 0.695 |
Positive | 35 | 54 | 89 | Â | Â | |
AFP# | Negative | 16 | 17 | 33 | 2.459 | 0.117 |
Positive | 15 | 33 | 48 | Â | Â | |
Cytokeratin-19 # | Negative | 29 | 35 | 64 | 4.176 | 0.041 |
Positive | 7 | 23 | 30 | Â | Â |